Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

NCT00004700 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.

NCT NCT00004700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
Lead sponsor
Children's Hospital of Philadelphia
Phase
Phase 2
Overall status
Completed
Start date
August 31, 1995
Completion date
January 31, 1999
Enrollment
16
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyperinsulinism